HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 24, No 12, December 2019 – Precision Medicine for Brain Tumours       » First Alzheimer's drug to be approved in 17 years holds promise for treatment       » Tencent make medical information readily available to the public       » United States FDA approves first China-made cancer drug       » Value-Based Healthcare: A Paradigm Shift for Better Patient Outcomes       » Precision Agriculture for Future Nutritional Needs      
INSIDE INDUSTRY
Russia creating its own ultrasound system to treat tumours
First prototype expected to be completed by the end of 2019

Shvabe Holding (part of Rostec State Corporation) and Peter the Great St. Petersburg Polytechnic University are working together to create the first Russian equipment for non-invasive tumour treatment.

The production of this new high-intensity focused ultrasound (HIFU) system will be organised in the Novosibirsk Instrument-making plant and first prototypes will be created by the end of 2019.

Non-invasive treatment is one of the safest ways to treat cancer. The HIFU system, that includes both hardware and software, will be designed for diagnostics and treatment of tumours in the mammary gland using focused high-intensity ultrasound. The system will consist of a power module, a medical stand with a monitor and control panel, a robotic manipulator unit, the ultrasound unit with a combined ultrasonic piezoelectric transducer for both diagnostics and treatment and the patient's seat with an immobiliser.

The first clinical tests are expected in 2020. After this, the project can obtain a registration certificate and start mass production.

"We see great potential for the supply of our high-tech medical equipment to highly-populated developing countries like India, China and the countries of Southeast Asia and Latin America," pointed Viktor Kladov, the Director for International Cooperation and Regional Policy Department of Rostec.

The project is financed by Novosibirsk Instrument-making plant, subsidiary of Shvabe Holding.

In the future, a whole new line of analogous devices might be created based on this project. These include devices intended for the treatment of tumours in the liver, prostate gland and brain.

Click here for the complete issue.

NEWS CRUNCH  
news Technology giant, Tencent Holdings Limited, promotes medical science and healthcare
news ECV2019 China Healthcare and Pharma Digital Innovation Summit Held Successfully in Shanghai — The "Highway" Era of Healthcare Digital Transformation
news Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
November:
Evaluating cost effectiveness of genomic profiling
December:
Precision Medicine for Brain Tumours
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy